Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E

Human and Experimental Toxicology

Volumn 21, Issue 12, 2002, Pages 635-641

  Gurbay A ^a,b   Garrel, C ^b   Osman, M ^b   Richard, M J ^b   Favier, A ^b   Hincal, Filiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Antioxidant enzymes; Ciprofloxacin; Cytotoxicity; Fibroblast cell culture; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; CIPROFLOXACIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID; MANGANESE SUPEROXIDE DISMUTASE; NEUTRAL RED; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUPEROXIDE DISMUTASE;

CANCER CELL CULTURE; CELL ASSAY; CELL COMPOSITION; CELL LINE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; INCUBATION TIME; LIPID PEROXIDATION; OBSERVATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TIME;

ADULT; ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; CATALASE; CELL SURVIVAL; CELLS, CULTURED; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; FIBROBLASTS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; SKIN; SUPEROXIDE DISMUTASE; VITAMIN E;

FELIS CATUS;

EID: 12244300522     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327102ht305oa     Document Type: Review

References (45)

1. Wolfson JS, Hooper DC. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 1985; 28: 581-86.
2. Blondeau JM. Expanded activity and utility of the new fluoroquinolones: a review. Clin Ther 1999; 21: 3-40.
3. Gellert M, Mizuuchi K, O'Dea MH, Itoh T, Tomizawa, JL, Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci USA 1977; 74: 4772-76.
4. Gootz TD, Barret JF, Holden HE, Ray VA, McGuirk PR. Selective toxicity: the activity of 4-quinolones against eukaryotic DNA topoisomerase. In Crumplin G ed. The 4-quinolones: antibacterial agents in vitro. London: Springer-Verlag, 1990: 159-71.
5. Hussy P, Maass G, Tummler B, Grosse F, Schomburg U. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase a primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother 1986; 29: 1073-78.
6. Hooper DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses, and toxicities in human. Antimicrob Agents Chemother 1985; 28: 716-21.
7. Grayson ML. Ciprofloxacin. In Kucers A, Crowe SM, Grayson ML, Hoy JF eds. The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs. Avon: The Bath Press, 1999: 981-1060.
8. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 1990; 26(Suppl B): 219-25.
9. Stahlmann R, Lode H. Safety overview. Toxicity, adverse effects, and drug interactions. In Andriole VT ed. The quinolones. San Diego: Academic Press, 1998: 369-415.
10. Stahlmann R, Lode H. Toxicity of quinolones. Drugs 1999; 58(Suppl): 37-42.
11. Nordmann P, Pechinot A, Kazmierczak A. Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and oxloxacin in primary cultures of rat hepatocytes. J Antimicrob Chemother 1989; 24: 355-63.
12. Forsgren A, Bredberg A, Pardee AB, Schlossman SF, Tedder TE. Effects of ciprofloxacin on eukaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother 1987; 31: 774-79.
13. Oomori Y, Yashuc T, Aoyama H, Hirai K, Suzue S, Yokota T. Effects of fleroxacin on HeLa cell functions and topoisomerase II. J Antimicrob Chemother 1988; 22(Suppl): 91-97.
14. Lawrence JW, Darkin-Rattray S, Xie F, Neims AH, Rowe TC. 4-quinolones causes a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. J Cell Biochem 1993; 51: 165-74.
15. Lawrence JW, Claire DC, Weisis V, Rowe TC. Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharmacol 1996; 50: 1178-88.
16. Zehavi-Willner T, Shalit I. The inhibitory effect of ciprofloxacin on proliferation of a murine bladder carcinoma cell line. J Antimicrob Chemother 1992; 29: 323-28.
17. Williams RJ III, Attia E, Wickiewicz TL, Hannafin JA. The effect of ciprofloxacin on tendon, paratendon, and capsular fibroblast metabolism. Am J Sports Med 2000; 28: 364-69.
18. Hayem G, Petit PX, Levacher M, Gaudin C, Kahn MF, Pocidalo JJ. Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial resistance. Antimicrob Agents Chemother 1994; 38: 243-47.
19. Wagai N, Tawara K. Quinolone antibacterial-agent-induced cutaneous phototoxicity: ear-swelling reactions in Balb/c mice. Toxicol Lett 1991; 58: 215-23.
20. Wagai N, Tawara K. Possible reasons for difference in phototoxic potential of 5-quinolone antibacterial agents: generation of toxic oxygen. Free Radic Res Commun 1992; 17: 387-98.
21. Wagai N, Tawara K. Possible direct role of reactive oxygens in the cause of cutaneous phototoxicity induced by five quinolones in mice. Arch Toxicol 1992; 66: 392-97.
22. Hincal F, Taskin T. The mechanism of convulsions induced by ciprofloxacin may involve the generation of free radicals and the activation of excitatory amino acid receptors. In Abstracts of the International Congress of Toxicology - VII. Seattle, Washington, Abstract 99, 1995: 27.
23. Gürbay A, Gonthier B, Daveloose D, Favier A, Hincal F. Microsomal metabolism of ciprofloxacin generates free radicals. Free Radic Biol Med 2000; 30: 1118-21.
24. Horn N. Copper incorporation studies on cultured cells for prenatal diagnosis of Menkes' disease. Lancet 1976; 1: 1156-58.
25. Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-24.
26. Richard MJ, Portal B, Meo J, Coudray C, Hadjian A, Favier A. Thiobarbituric acid reactant determination in plasma and lipoprotein fractions. Evaluation of Sobioda MDA-kit. Clin Chem 1992; 38: 704-709.
27. Akerboom TPM, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981; 77: 373-82.
28. Emonet N, Leccia MT, Favier A, Beani JC, Richard MJ. Thiols and selenium: protective effect on human skin fibroblasts exposed to UVA irradiation. J Photochem Photobiol B 1997; 40: 84-90.
29. Parat M-O, Richard MJ, Beani JC, Favier A. Involvement of zinc in cellular oxidant/antioxidant balance. Biol Trace Elem Res 1998; 60: 187-204.
30. Gunzler WA, Kremers H, Flohe L. An improved test procedure for glutathione peroxidase in blood. Z Klin Chem Klin 1974; 12: 444-48.
31. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-25.
32. Shopsis C, Mackay GJ. Semi-automated assay for cell culture. Anal Biochem 1984; 140: 104-107.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall, RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
34. Murrell GA, Francis MJO, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990; 265: 659-65.
35. Los M, Droge W, Stricker K, Baeuerle P, Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 1995; 25: 159-65.
36. Schafer D, Hamm-Kunzelmann B, Hermfisse U, Brand K. Differences in DNA-binding efficiency of Sp 1 to aldolase and pyruvate kinase promoter correlate with altered redox states in resting and proliferating rat thymocytes. FEBS Lett 1996; 391: 35-38.
37. Seve M, Favier A, Osman M, Vaitaitis G, McCord JM, Flores SC. The human immunodeficiency virus-1 tat protein increases sensitivity to zinc chelator-induced apoptosis and changes Sp1 DNA binding in HeLa cells. Arch Biochem Biophys 1999; 351: 165-72.
38. Buttke T, Dandstrom P. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10.
39. Pani G, Colavitti R, Bedogni B, Anzevino R, Borrello S, Galeotti T. A redox signalling mechanism for density-dependent inhibition of cell growth. J Biol Chem 2000; 275: 38891-99.
40. Baudhuin P. Cytologie et biologie cellulaire. Louvain: Acco, 1975: 120-23.
41. Gavino VC, Miller JS, Ikharebba SO, Milo GE, Cornwell DG. Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J Lipid Res 1981; 22: 763-69.
42. Lindsey JA, Zhang H, Kaseki H, Morisaki N, Sato T, Cornwell DG. Fatty acid metabolism and cell proliferation. VII. Antioxidant effects of tocopherols and their quinones. Lipids 1985; 20: 151-57.
43. Ingold KU, Webb AC, Witter D, Burton GW, Metcalfe TA, Muller DPR. Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch Biochem Biophys 1987; 259: 224-25.
44. Reed DJ. Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 1990; 30: 603-31.
45. Sörgel F. Metabolism of gyrase inhibitors. Rev Infect Dis 1989; 11(Suppl): S1119-29.